Document is current
Any future updates will be listed below
-
Authors
Han, Rui https://orcid.org/0000-0003-4782-3998
Zhu, Yuejie https://orcid.org/0000-0002-6088-8991
Zhang, Xiaoting https://orcid.org/0009-0004-6670-6599
Liu, Xiaoran https://orcid.org/0000-0002-7459-3852
Xia, Yan https://orcid.org/0000-0002-3448-4977
Ye, Erdengqieqieke https://orcid.org/0009-0001-4303-9437
La, Xiaolin https://orcid.org/0000-0002-9793-2853
Ding, Jianbing https://orcid.org/0000-0001-5506-7665
-
Funding
Funding for this research was provided by:
State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia，Xinjiang Medical University (SKL-HIDCA-2024-GX3)
Natural Science Foundation of Xinjiang Uygur Autonomous Region (2022D01C468)
- License Information
-
More Information
Article History
Received: 13 August 2024
Accepted: 12 November 2024
First Online: 11 December 2024
Declarations
:
: The First Affiliated Hospital of Xinjiang Medical University's Ethics Committee approved the study (Ethical Approval Number K202305-02), and all individual signed the informed consent form.
: The authors declare that there are no direct or indirect conflicts of interest related to the content, conclusions, or interpretation of the study titled “Upregulation of PD-L1 contributes to improving the apoptosis of granulosa cells via the PI3K/AKT pathway in PCOS,” submitted to the Journal of Assisted Reproduction and Genetics. We confirm that no funding, goods, or services have been received that could potentially influence the impartiality of this research. In addition, the authors have no affiliations or collaborations with any organizations or individuals that have a direct or indirect competing interest in this research.
